Modeling HIV-1 drug resistance as episodic directional selection
about
The genomes of many yam species contain transcriptionally active endogenous geminiviral sequences that may be functionally expressedLess is more: an adaptive branch-site random effects model for efficient detection of episodic diversifying selectionInferring influenza global transmission networks without complete phylogenetic information.The Influence of HIV on the Evolution of Mycobacterium tuberculosis.Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models.On the validity of evolutionary models with site-specific parameters.Gene-wide identification of episodic selectionFUBAR: a fast, unconstrained bayesian approximation for inferring selection.Evolutionary Dynamics of Floral Homeotic Transcription Factor Protein-Protein Interactions.Finding Direction in the Search for Selection.A Comparison of One-Rate and Two-Rate Inference Frameworks for Site-Specific dN/dS Estimation.Porcine circovirus type 2 (PCV2) evolution before and after the vaccination introduction: A large scale epidemiological study.Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors.On the statistical interpretation of site-specific variables in phylogeny-based substitution models.Intrapatient viral diversity and treatment outcome in patients with genotype 3a hepatitis C virus infection on sofosbuvir-containing regimens.Plant Actin-Depolymerizing Factors Possess Opposing Biochemical Properties Arising from Key Amino Acid Changes throughout Evolution.Molecular adaptation in Rubisco: Discriminating between convergent evolution and positive selection using mechanistic and classical codon models.
P2860
Q28596151-B4FEF0A8-0F33-4635-9505-A3F15BDB4AACQ28648488-B262784D-796F-406E-AD01-BFA8187EFCB3Q30360590-B88DADF2-34AD-4CC3-9E2B-1DC46896FD0CQ33757201-F11C9693-C1BA-4272-857B-5C2B5DEC1616Q34455457-5C72BD1F-D8F6-4E87-B1FE-0B1348BE9673Q35145393-39149E81-5C29-4E85-9FCF-92902417DA76Q35533905-982DED24-2CE2-437D-BB7B-B2B992ACD29EQ36896951-51D73E6E-270E-4683-BE88-EA8E198D807FQ36904228-E8A76D14-8398-4D79-9298-ACD1DCD58012Q39134473-D1A12309-65FA-4D20-A935-C9B82AC90DA4Q39479453-6ED75B39-493B-4B1A-9AC1-8318137B63BAQ39500288-8F657DE5-9AF9-4589-B17A-D5CE83EF3D8CQ40039995-04B3676C-0A96-4D3E-BB01-075EB4BEA0F1Q43197803-8B5D75C8-3868-41D6-9C68-85F8DF189812Q45325188-CE9D6702-DCA2-43A9-A540-B466DC421A53Q48310974-E5381AB5-71BE-477F-94DC-07F0F2FA7BDFQ50047267-89BC88AC-ABDB-4E84-B7ED-9895F2C8EEA2
P2860
Modeling HIV-1 drug resistance as episodic directional selection
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Modeling HIV-1 drug resistance as episodic directional selection
@ast
Modeling HIV-1 drug resistance as episodic directional selection
@en
Modeling HIV-1 drug resistance as episodic directional selection
@nl
type
label
Modeling HIV-1 drug resistance as episodic directional selection
@ast
Modeling HIV-1 drug resistance as episodic directional selection
@en
Modeling HIV-1 drug resistance as episodic directional selection
@nl
prefLabel
Modeling HIV-1 drug resistance as episodic directional selection
@ast
Modeling HIV-1 drug resistance as episodic directional selection
@en
Modeling HIV-1 drug resistance as episodic directional selection
@nl
P2860
P50
P1476
Modeling HIV-1 drug resistance as episodic directional selection
@en
P2093
Chris Seebregts
P2860
P304
P356
10.1371/JOURNAL.PCBI.1002507
P407
P577
2012-01-01T00:00:00Z